XK and infection: When administered to mice prior to exposure to a panel of influenza B viruses, the anti-NA sera were as potent as the anti-HA sera in providing protection against homologous challenge and, in some instances, conferred enhanced protection against infection with heterologous influenza B virus strains [35].